[go: up one dir, main page]

ES2143973T3 - Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos. - Google Patents

Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos.

Info

Publication number
ES2143973T3
ES2143973T3 ES90110023T ES90110023T ES2143973T3 ES 2143973 T3 ES2143973 T3 ES 2143973T3 ES 90110023 T ES90110023 T ES 90110023T ES 90110023 T ES90110023 T ES 90110023T ES 2143973 T3 ES2143973 T3 ES 2143973T3
Authority
ES
Spain
Prior art keywords
acids
well
amino
preparation
quinoloncarboxilicos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110023T
Other languages
English (en)
Inventor
Uwe Dr Petersen
Andreas Dr Krebs
Thomas Dr Schenke
Klaus Dr Grohe
Michael Dr Schriewer
Ingo Dr Haller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2143973T3 publication Critical patent/ES2143973T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)

Abstract

EL PRESENTE INVENTO CONCIERNE A LA PRODUCCION DE LOS COMPUESTOS CITADOS, DE FORMULA GENERAL I (FORMULA) EN LA QUE X, R1 A R6 TIENEN EL SIGNIFICADO DADO EN LA MEMORIA. SE CONOCEN COMO SUSTANCIAS ANTIBACTERIANAS Y SE PREPARAN POR REACCION DE LOS ACIDOS 7-HALOGENO-3-QUINOLONA-CARBOXILICOS O NAFTIRIDONA-CARBOXILICOS CON 3-AMINOPIRROLIDINA O 3-AMINOMETILPIRROLIDINA, EN FORMA LIBRE O EN FORMA DE 3-ACILAMINO-PIRROLIDINA O 3-ACILAMINOMETILPIRROLIDINA, Y POR SEPARACION POSTERIOR DE LOS GRUPOS ACILO.
ES90110023T 1989-06-07 1990-05-26 Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos. Expired - Lifetime ES2143973T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918544A DE3918544A1 (de) 1989-06-07 1989-06-07 Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren

Publications (1)

Publication Number Publication Date
ES2143973T3 true ES2143973T3 (es) 2000-06-01

Family

ID=6382248

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110023T Expired - Lifetime ES2143973T3 (es) 1989-06-07 1990-05-26 Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos.

Country Status (8)

Country Link
US (3) US5061712A (es)
EP (1) EP0401623B1 (es)
JP (1) JP2799222B2 (es)
AT (1) ATE189220T1 (es)
DE (2) DE3918544A1 (es)
DK (1) DK0401623T3 (es)
ES (1) ES2143973T3 (es)
GR (1) GR3033099T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190955A (en) * 1987-01-28 1993-03-02 Bayer Aktiengesellschaft Antibacterial 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
KR950005301B1 (ko) * 1990-09-04 1995-05-23 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
CA2110260C (en) * 1991-05-28 2001-12-04 Isao Hayakawa Pyridonecarboxylic acid derivatives
FR2690161B1 (fr) * 1992-04-16 1995-06-30 Esteve Labor Dr Derives de pyridone azetidinyl substitues avec activite antimicrobienne.
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
CA2152828A1 (en) * 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
AU679961B2 (en) * 1993-08-13 1997-07-17 Dong Wha Pharmaceutical Industrial Co., Ltd. Novel quinolone carboxylic acid derivatives
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
FR2916446B1 (fr) * 2007-05-24 2009-08-21 Biocodex Sa Nouveau procede de synthese de fluoroquinolones

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2739313A1 (de) * 1977-09-01 1979-03-15 Bayer Ag Cycloaminale, ein verfahren zu ihrer herstellung, sowie ihre verwendung
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
DE3409922A1 (de) * 1984-03-17 1985-09-26 Bayer Ag, 5090 Leverkusen 1,7-diamino-1,4-dihydro-4-oxo-3-(aza)chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung bakterieller erkrankungen
IN162769B (es) * 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
AU578793B2 (en) * 1985-02-15 1988-11-03 Dainippon Pharmaceutical Co. Ltd. Novel 1,8-naphthyridine derivatives and processes for preparation thereof
HUT40639A (en) * 1985-03-08 1987-01-28 Kyorin Seiyaku Kk Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
US4762845A (en) * 1986-05-21 1988-08-09 Abbott Laboratories 7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids
EP0259804B1 (de) * 1986-09-12 1993-11-18 F. Hoffmann-La Roche Ag Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents

Also Published As

Publication number Publication date
EP0401623A1 (de) 1990-12-12
DE3918544A1 (de) 1990-12-13
JPH0324074A (ja) 1991-02-01
EP0401623B1 (de) 2000-01-26
DE59010896D1 (de) 2000-03-02
JP2799222B2 (ja) 1998-09-17
US5648493A (en) 1997-07-15
DK0401623T3 (da) 2000-07-17
ATE189220T1 (de) 2000-02-15
GR3033099T3 (en) 2000-08-31
US5061712A (en) 1991-10-29
US5723627A (en) 1998-03-03

Similar Documents

Publication Publication Date Title
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
PT77344A (en) Process for the preparation of new diazabicyclo-3,3,1-nonanes
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
DE69123000D1 (de) Neue tricyclische Verbindung oder Salze davon, Verfahren zur Herstellung und antimikrobieller Wirkstoff, der sie enthält
FI931332A0 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
ES2143973T3 (es) Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos.
ES2058963T3 (es) Dihidropiridinas substituidas heterociclicamente, procedimiento para su fabricacion y su uso en medicamentos.
PT93702A (pt) Processo para a preparacao de 2,7-diazabiciclo{3.3.0}octanos e de produtos intermediarios
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
HUT35680A (en) Process for preparing purine derivatives
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
ZA9710960B (en) Substituted tetrahydropyridine compounds, process for preparing them and pharmaceutical compositions containing them.
ES2089157T3 (es) Nuevos derivados de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
FI915875L (fi) Menetelmä yleisen kaavan I mukaisten lääkeaineina käyttökelpoisten 2,3-dihydro-4H-1,3-bentsoksatsinon-4-onien ja 2,3-dihydro-4H-bentsotiatsinon-4-onien nitro-oksijohdannaisten valmistamiseksi
DE3781879D1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
HUT43614A (en) Process for producing isohexide-nucleosides and pharmaceutical compositions containing them
ES526922A0 (es) Un procedimiento para producir derivados de antraciclina
IT1237529B (it) Composti spiro-indolino-ossazine con caratteristiche fotocromatiche e fotosensibilizzatrici e procedimento per la loro preparazione
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
HUT55033A (en) Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ES2052483T1 (es) Nuevos derivados del 3,3,5-trimetilciclohexanol, su procedimiento de preparacion asi como las composiciones terapeuticas que los contienen.
ES2112597T3 (es) Nuevos derivados de 17-(3-imino-2-alquil-propenil)-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401623

Country of ref document: ES